Deep sequencing reveals potential antigenic variants at low frequencies in influenza A virus-infected humans

Journal of Virology

Volumn 90, Issue 7, 2016, Pages 3355-3365

  Dinis, Jorge M ^a   Florek, Nicholas W ^a   Fatola, Omolayo O ^b   Moncla, Louise H ^a   Mutschler, James P ^a,d   Charlier, Olivia K ^a   Meece, Jennifer K ^c   Belongia, Edward A ^c   Friedrich, Thomas C ^a,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c MARSHFIELD CLINIC   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; CYSTEINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HEMAGGLUTININ; HISTIDINE; LYSINE; THREONINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ARTICLE; CHILD; CLADISTICS; CONTROLLED STUDY; DEEP SEQUENCING; EVOLUTION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC DISTANCE; GENETIC VARIABILITY; HA GENE; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA A VIRUS (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING DOMAIN; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VACCINE FAILURE; VIRAL GENETICS; VIRUS GENE; DNA SEQUENCE; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNE EVASION; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H3N2); MIDDLE AGED; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ANTIGENS, VIRAL; CHILD; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNE EVASION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; VACCINATION; YOUNG ADULT;

EID: 84960968294     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03248-15     Document Type: Article

References (53)

1. World Health Organization. 2014. Influenza. Fact sheet 211. Accessed 4 May 2015. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs211/en/.
2. Osterholm MT, Kelley NS, Sommer A, Belongia EA. 2012. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12:36-44. http://dx.doi.org/10.1016/S1473-3099(11)70295-X.
3. McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM, Jackson ML, Jackson L, Ohmit SE, Petrie JG, Monto AS, Meece JK, Thaker SN, Clippard JR, Spencer SM, Fry AM, Belongia EA. 2014. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 211:1529-1540. http://dx.doi.org/10.1093/infdis/jiu647.
4. Flannery B, Thaker SN, Clippard J, Monto AS, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Berman L, Foust A, Sessions W, Spencer S, Fry AM. 2014. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness-United States, February 2014. MMWR Morb Mortal Wkly Rep 63:137-142.
5. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, Gaglani M, Berman L, Foust A, Sessions W, Thaker SN, Spencer S, Fry AM. 2015. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep 64:10-15.
6. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326:734-736. http://dx.doi.org/10.1126/science.1178258.
7. Kryazhimskiy S, DushoffJ, Bazykin GA, Plotkin JB. 2011. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet 7:e1001301. http://dx.doi.org/10.1371/journal.pgen.1001301.
8. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378. http://dx.doi.org/10.1038/289373a0.
9. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427. http://dx.doi.org/10.1016/0092-8674(82)90135-0.
10. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. http://dx.doi.org/10.1126/science.1097211.
11. Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, McCauley JW, Russell CA, Smith DJ, Rambaut A. 2014. Integrating influenza antigenic dynamics with molecular evolution. eLife 3:e01914. http://dx.doi.org/10.7554/eLife.01914.
12. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. 2013. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342:976-979. http://dx.doi.org/10.1126/science.1244730.
13. Koel BF, Mogling R, Chutinimitkul S, Fraaij PL, Burke DF, van der Vliet S, de Wit E, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Smith DJ, Fouchier RA, de Graaf M. 2015. Identification of amino acid substitutions supporting antigenic change of A(H1N1)pdm09 viruses. J Virol 89:3763-3775. http://dx.doi.org/10.1128/JVI.02962-14.
14. Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. 2010. Viral mutation rates. J Virol 84:9733-9748. http://dx.doi.org/10.1128/JVI.00694-10.
15. Drake JW, Holland JJ. 1999. Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96:13910-13913. http://dx.doi.org/10.1073/pnas.96.24.13910.
16. Lauring AS, Frydman J, Andino R. 2013. The role of mutational robustness in RNA virus evolution. Nat Rev Microbiol 11:327-336. http://dx.doi.org/10.1038/nrmicro3003.
17. Domingo E, Sheldon J, Perales C. 2012. Viral quasispecies evolution. Microbiol Mol Biol Rev 76:159-216. http://dx.doi.org/10.1128/MMBR.05023-11.
18. Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, Desany B, Rothberg JM, Egholm M, Kozal MJ, Terry Beirn Community Programs for Clinical Research on, AIDS. 2009. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J Infect Dis 199:693-701. http://dx.doi.org/10.1086/596736.
19. Ghedin E, Holmes EC, DePasse JV, Pinilla LT, Fitch A, Hamelin ME, Papenburg J, Boivin G. 2012. Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission. J Infect Dis 206:1504-1511. http://dx.doi.org/10.1093/infdis/jis571.
20. Wilker PR, Dinis JM, Starrett G, Imai M, Hatta M, Nelson CW, O'Connor DH, Hughes AL, Neumann G, Kawaoka Y, Friedrich TC. 2013. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nat Commun 4:2636. http://dx.doi.org/10.1038/ncomms3636.
21. Greenlee RT. 2003. Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA). Clin Med Res 1:273-280. http://dx.doi.org/10.3121/cmr.1.4.273.
22. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, Jackson L, Meece JK, Nowalk MP, Song J, Zervos M, Cheng PY, Rinaldo CR, Clipper L, Shay DK, Piedra P, Monto AS. 2014. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 58:319-327. http://dx.doi.org/10.1093/cid/cit736.
23. Centers for Disease Control and Prevention. 2013. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2013. MMWR Morb Mortal Wkly Rep 62:32-35.
24. Skehel JJ, Hay AJ. 1978. Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts. Nucleic Acids Res 5:1207-1219. http://dx.doi.org/10.1093/nar/5.4.1207.
25. Edgar RC. 2004. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5:113. http://dx.doi.org/10.1186/1471-2105-5-113.
26. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. 2010. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59:307-321. http://dx.doi.org/10.1093/sysbio/syq010.
27. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52:696-704. http://dx.doi.org/10.1080/10635150390235520.
28. Kofler R, Orozco-ter Wengel P, De Maio N, Pandey RV, Nolte V, Futschik A, Kosiol C, Schlotterer C. 2011. PoPoolation: a toolbox for population genetic analysis of next generation sequencing data from pooled individuals. PLoS One 6:e15925. http://dx.doi.org/10.1371/journal.pone.0015925.
29. Wang ML, Katz JM, Webster RG. 1989. Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. Virology 171:275-279. http://dx.doi.org/10.1016/0042-6822(89)90538-2.
30. Robertson JS, Bootman JS, Newman R, Oxford JS, Daniels RS, Webster RG, Schild GC. 1987. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology 160: 31-37. http://dx.doi.org/10.1016/0042-6822(87)90040-7.
31. Schild GC, Oxford JS, de Jong JC, Webster RG. 1983. Evidence for host-cell selection of influenza virus antigenic variants. Nature 303:706-709. http://dx.doi.org/10.1038/303706a0.
32. Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, Bertoni A, Swerdlow HP, Gu Y. 2012. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences, and Illumina MiSeq sequencers. BMCGenomics 13:341. http://dx.doi.org/10.1186/1471-2164-13-341.
33. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J, Pallen MJ. 2012. Performance comparison of benchtop highthroughput sequencing platforms. Nat Biotechnol 30:434-439. http://dx.doi.org/10.1038/nbt.2198.
34. European Centre for Disease Prevention and Control. 2013. Influenza virus characterisation, Summary Europe, July 2013. European Centre for Disease Prevention and Control, Solna, Sweden.
35. European Centre for Disease Prevention and Control. 2014. Influenza virus characterisation, Summary Europe, July 2014. European Centre for Disease Prevention and Control, Solna, Sweden.
36. Jin H, Zhou H, Liu H, Chan W, Adhikary L, Mahmood K, Lee MS, Kemble G. 2005. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336:113-119. http://dx.doi.org/10.1016/j.virol.2005.03.010.
37. Barr IG, Russell C, Besselaar TG, Cox NJ, Daniels RS, Donis R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Schultz-Cherry S, Shu Y, Smith D, Tashiro M, Wang D, Webby R, Xu X, Ye Z, Zhang W. 2014.WHOrecommendations for the viruses used in the 2013-2014 northern hemisphere influenza vaccine: epidemiology, antigenic, and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine 32:4713-4725. http://dx.doi.org/10.1016/j.vaccine.2014.02.014.
38. Nakajima S, Nakajima K, Nobusawa E, Zhao J, Tanaka S, Fukuzawa K. 2007. Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody. Microbiol Immunol 51:1179-1187. http://dx.doi.org/10.1111/j.1348-0421.2007.tb04013.x.
39. Neher RA, Bedford T. 2015. nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics 31:3546-3548. http://dx.doi.org/10.1093/bioinformatics/btv381.
40. Squires RB, Noronha J, Hunt V, García-Sastre A, Macken C, Baumgarth N, Suarez D, Pickett BE, Zhang Y, Larsen CN, Ramsey A, Zhou L, Zaremba S, Kumar S, Deitrich J, Klem E, Scheuermann RH. 2012. Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses 6:404-416. http://dx.doi.org/10.1111/j.1750-2659.2011.00331.x.
41. Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, Hensley SE. 2013. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med 210:1493-1500. http://dx.doi.org/10.1084/jem.20130212.
42. Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, Petrie S, McCaw JM, McVernon J, Hurt AC, Kelso A, Mosse J, Barr IG, Laurie KL. 2013. Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model. PLoS Pathog 9:e1003354. http://dx.doi.org/10.1371/journal.ppat.1003354.
43. Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. 2013. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med 5:198ra107. http://dx.doi.org/10.1126/scitranslmed.3006637.
44. Fazekas DSG, Webster RG. 1966. Disquisitions of original antigenic sin. I. Evidence in man. J Exp Med 124:331-345.
45. Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WE, Le QM, Nguyen TH, Wertheim HF, Hurt AC, Osterhaus AD, Barr IG, Fouchier RA, Horby PW, Smith DJ. 2014. Antibody landscapes after influenza virus infection or vaccination. Science 346:996-1000. http://dx.doi.org/10.1126/science.1256427.
46. Murcia PR, Baillie GJ, Stack JC, Jervis C, Elton D, Mumford JA, Daly J, Kellam P, Grenfell BT, Holmes EC, Wood JL. 2013. Evolution of equine influenza virus in vaccinated horses. J Virol 87:4768-4771. http://dx.doi.org/10.1128/JVI.03379-12.
47. Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. 2013. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe 13:314-323. http://dx.doi.org/10.1016/j.chom.2013.02.008.
48. Illingworth CJ, Fischer A, Mustonen V. 2014. Identifying selection in the within-host evolution of influenza using viral sequence data. PLoS Comput Biol 10:e1003755. http://dx.doi.org/10.1371/journal.pcbi.1003755.
49. Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y. 2014. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 9:e92153. http://dx.doi.org/10.1371/journal.pone.0092153.
50. World Health Organization. 2014. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec 89:93-104.
51. O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, Li GM, McCausland M, Zheng NY, Yewdell JW, Ahmed R, Wilson PC, Subbarao K. 2012. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. mBio 3:e00120-12. http://dx.doi.org/10.1128/mBio.00120-12.
52. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. 2008. The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340-346. http://dx.doi.org/10.1126/science.1154137.
53. Weis WI, Brunger AT, Skehel JJ, Wiley DC. 1990. Refinement of the influenza virus hemagglutinin by simulated annealing. J Mol Biol 212: 737-761. http://dx.doi.org/10.1016/0022-2836(90)90234-D.